1. Home
  2. LPTH vs VOR Comparison

LPTH vs VOR Comparison

Compare LPTH & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$14.29

Market Cap

563.1M

Sector

Technology

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$15.97

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPTH
VOR
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
563.1M
755.7M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
LPTH
VOR
Price
$14.29
$15.97
Analyst Decision
Strong Buy
Buy
Analyst Count
3
10
Target Price
$13.33
$45.44
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,202,630.00
N/A
Revenue This Year
$83.04
N/A
Revenue Next Year
$24.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.26
N/A
52 Week Low
$1.85
$0.13
52 Week High
$15.24
$49.95

Technical Indicators

Market Signals
Indicator
LPTH
VOR
Relative Strength Index (RSI) 66.61 54.63
Support Level $9.60 $11.38
Resistance Level $15.24 $16.88
Average True Range (ATR) 1.14 1.62
MACD 0.35 0.07
Stochastic Oscillator 92.29 52.41

Price Performance

Historical Comparison
LPTH
VOR

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: